---
title: Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial
date: '2024-09-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39330966/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240928190141&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: In a three-dose schedule (two primary doses and a booster),
  40% doses of PCV13 were noninferior to full doses for all included serotypes. Lower
  doses of PCV13 and PCV10 did not meet the criteria for noninferiority. (Funded by
  the Bill and Melinda Gates Foundation and others; ClinicalTrials.gov number, NCT03489018;
  Pan African Clinical Trial Registry number, PACTR202104717648755.). ...'
disable_comments: true
---
CONCLUSIONS: In a three-dose schedule (two primary doses and a booster), 40% doses of PCV13 were noninferior to full doses for all included serotypes. Lower doses of PCV13 and PCV10 did not meet the criteria for noninferiority. (Funded by the Bill and Melinda Gates Foundation and others; ClinicalTrials.gov number, NCT03489018; Pan African Clinical Trial Registry number, PACTR202104717648755.). ...